Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2010
Revenues:
Industrialization and development fees	$ 249		$ 1,689	$ 1,350
Licensing fees	646	630	1,318	1,207
Product sales and other	17	1,132	35	2,748
Total revenues	912	1,762	3,042	5,305
Cost of product sales	16	824	90	1,999
Gross profit	896	938	2,952	3,306
Operating expenses:
Research and development	5,262	2,442	9,560	4,218
Selling, general and administrative	6,712	8,028	12,895	15,269
Depreciation and amortization	1,157	878	2,150	1,665
Total operating expenses	13,131	11,348	24,605	21,152
Operating loss	(12,235)	(10,410)	(21,653)	(17,846)
Interest expense	639	32	922	64
Interest income	(26)	(82)	(56)	(204)
Other expense (income), net	2	(2)	36	(102)
Net loss	$ (12,850)	$ (10,358)	$ (22,555)	$ (17,604)
Loss per share:
Basic and diluted loss per share	$ (0.19)	$ (0.19)	$ (0.35)	$ (0.32)